Long-Lasting Reduction of Blood Pressure by Electroacupuncture in Patients with Hypertension: Randomized Controlled

Peng Li1, Stephanie C Tjen-A-Looi1, Ling Cheng2

  • 1Susan-Samueli Center for Integrative Medicine, University of California , Irvine, School of Medicine, Irvine, CA.

Medical Acupuncture
|September 23, 2015
PubMed

Insights

Electroacupuncture (EA) at specific acupoints effectively lowers blood pressure in hypertensive patients. This treatment also reduced key markers of the sympathetic and renin-aldosterone systems.

Area of Science:

  • Integrative Medicine
  • Cardiovascular Research
  • Neuroscience

Background:

  • Acupuncture shows potential for managing chronic hypertension.
  • Electroacupuncture (EA) targets specific acupoints to influence physiological responses.

Purpose of the Study:

  • To evaluate the efficacy of EA at specific acupoints for reducing systolic blood pressure (SBP) and diastolic blood pressure (DBP).
  • To investigate the impact of EA on the sympathetic and renin-aldosterone systems in hypertensive patients.

Main Methods:

  • A two-arm parallel study involving 65 hypertensive patients not on medication.
  • Patients received 8 weeks of once-weekly 30-minute EA treatments at either PC 5-6+ST 36-37 or control acupoints (LI 6-7+GB 37-39).
  • Blood pressure was monitored using 24-hour ambulatory monitoring, with plasma norepinephrine, renin, and aldosterone levels assessed pre- and post-treatment.

Main Results:

  • EA at PC 5-6+ST 36-37 significantly reduced peak and average SBP and DBP compared to control acupoints.
  • A sustained blood pressure-lowering effect was observed in some patients for up to 4 weeks after treatment cessation.
  • Post-treatment levels of norepinephrine, renin, and aldosterone decreased by 41%, 67%, and 22% respectively.

Conclusions:

  • EA at specific acupoints, particularly PC 5-6+ST 36-37, is effective in lowering blood pressure in hypertensive individuals.
  • The observed long-lasting effects of EA are likely mediated by modulation of the sympathetic and renin-aldosterone systems.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.4K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.8K
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
2.2K
Antihypertensive Drugs: Action of Diuretics01:16

Antihypertensive Drugs: Action of Diuretics

Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
2.8K